Idiopathic Isolated Rapid Eye Movement Behavior Disorder clinical trials

Explore recruiting idiopathic isolated rapid eye movement behavior disorder clinical trials.

Also recruiting in Europe

Idiopathic Isolated Rapid Eye Movement Behavior Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label sleep laboratory study of efficacy and safety of piromelatine in a well-defined population of patients with idiopathic (isolated) Rapid Eye Movement Behavior Disorder (iRBD).

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Idiopathic Isolated Rapid Eye Movement Behavior Disorder trials by city

Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Toronto Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Vancouver Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Montreal Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Calgary Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Edmonton Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Ottawa Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Winnipeg Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Quebec City Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Hamilton Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Kitchener Idiopathic Isolated Rapid Eye Movement Behavior Disorder in London Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Halifax Idiopathic Isolated Rapid Eye Movement Behavior Disorder in New York Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Los Angeles Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Chicago Idiopathic Isolated Rapid Eye Movement Behavior Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease